About Ribo
Science
Pipeline
Collaboration
Careers
Contact Information
About Ribo
International R&D Center
Our Story
Leadership Team
Scientific Advisory Board
News
About Oligonucleotide Therapeutics
Technological Innovations
Intellectual Property
Therapeutic Area
Pipeline
Products
Clinical Trials
BD and Collaboration
Our Culture
Career Development
Recruitment
Contact Information
CN
B3-pcbanner.jpg B3-phbanner.jpg
News
About RiboNews
Ribo was selected as one of 2019 "Most Innovative Pharmaceutical Companies in Asia" by Clarivate Analytics
Sep 03,2019
Last : Ribo completed the enrollment of the first patient into the Chinese phase II clinical trial on ASOISIS449884 Injection
Next : Ribo's clinical application for new oligonucleotide therapeutics in the treatment of type 2 diabetes got approved